Advent Life Sciences

Advent Life Sciences is a leading transatlantic venture capital firm established in London in 2006. It specializes in investing and building innovative life sciences businesses across the UK, Europe, and the USA. The firm focuses on new drug discovery across all modalities—including small molecules and biologics—medtech devices, enabling technologies, diagnostics, and vaccines. Since inception it has backed over fifteen medicines/products that have reached approval through its hands-on approach with management teams. Its investment strategy spans pre-seed to late-stage rounds with an emphasis on first-in-class or best-in-class approaches addressing unmet medical needs.